Interleukin-6 stimulates hepatic insulin-like growth factor binding protein-4 messenger ribonucleic acid and protein

Endocrinology

Volumn 142, Issue 1, 2001, Pages 241-248

  Fernández Celemín, Laura ^a   Thissen, Jean Paul ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYCLOHEXIMIDE; CYTOKINE; DACTINOMYCIN; DEXAMETHASONE; ENDOTOXIN; GLUCOCORTICOID; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GENE EXPRESSION; LIGAND BINDING; LIVER CELL CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; SEPSIS; TRANSCRIPTION REGULATION;

EID: 0035111342     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.1.7903     Document Type: Article

References (52)

1. Insulin-like growth factor-I production is inhibited in human sepsis
2. Differential tissue regulation of Insulin-like Growth Factor-I content and binding proteins after endotoxin
3. GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors
4. Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone
5. Differential effects of insulin-like growth factor I (IGF-I) and IGF-binding protein-1 on protein metabolism in human skeletal muscle cells
6. Regulation of Insulin-like Growth Factor- I (IGF-I) and IGF binding proteins by tumor necrosis factor
7. Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1
8. Proinflammatory cytokines interleukin 1β and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells
9. Inhibition by interleukin-1β and tumor necrosis factor-α of the insulin-like growth factor α messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture
10. Dexamethasone increases hepatic insulin-like growth factor-I (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat
11. The regulation of insulin-like growth factor-binding protein 1 messenger ribonucleic acid in cultured rat hepatocytes: The roles of glucagon and growth hormone
12. IL-6 stimulation of insulin-like growth factor binding protein (IGFBP)production
13. Regulation of IGF binding protein-1 in hep G2 cells by cytokines and reactive oxygen species
14. Insulin-like growth factor binding proteins in serum and other biological fluids: Regulation and functions
15. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast
16. Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-I-induced myogenesis in rat L6E9 cells
17. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions
18. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: A dual role for IGFBP-5
19. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle α-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia
20. Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin
21. Effects of endotoxin lipopolysaccharide administration on the somatotropic axis
22. Circulating insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and tissue mRNA levels of IGFBP-2 and IGFBP-4 in the ovine fetus
23. Tri-iodothyronine increases insulin-like growth factor binding protein-4 expression in rat hepatocytes
24. Use of hepatocyte culture in study of P450 regulation
25. Somatomedin-C/insulin-like growth factor I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues
26. Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF- binding proteins in serum
27. Characterization of an insulin-like growth factor binding protein (IGFBP-4) produced by the B104 rat neuronal cell line: Chemical and biological properties and differential synthesis by sublines
28. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome
29. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?
30. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I-a model for stunted growth in children with chronic inflammation
31. Induction of rat acute-phase proteins by interleukin 6 in vivo
32. Regulation of α2-macroglobulin gene expression by interleukin-6 (BSF-2/HSF)
33. A stable long-term hepatocyte culture system for studies of physiologic processes: Cytokine stimulation of the acute phase response in rat and human hepatocytes
34. The insulin-like growth factor-binding protein-4 (IGFBP-4)-protease system in normal human osteoblast-like cells: Regulation by transforming growth factor-β
35. Heterogeneous modulation of acute-phase-reactant mRNA levels by interleukin-1β and interleukin-6 in the human hepatoma cell line PLC/PRF/5
36. Regulation of angiogenin expression in human HepG2 hepatoma cells by mediators of the acute-phase response
37. Glucocorticoid regulation of an insulin-like growth factor-binding protein-4 protease produced by a rat neuronal cell line
38. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
39. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: Potential implications for the syndrome of inappropriate vasopressin secretion
40. Acute stimulation of the hypothalamic-pituitary-adrenal axis by IL-1β, TNFα and IL-6: A dose response study
41. Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells
42. Differential regulation of interleukin-6 receptor and gp130 gene expression in rat hepatocytes
43. Characterization of the IL-6 responsive elements in the gamma fibrinogen gene promoter
44. Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: Synergistic activation of IL-6 response element by IL-6 and glucocorticoid
45. Interleukin-6 and the acute phase response
46. Interaction of cytokine- and glucocorticoid-response elements of acute-phase plasma protein genes. Importance of glucocorticoid receptor level and cell type for regulation of the elements from rat α1-acid glycoprotein and β-fibrinogen genes
47. Cytokine signaling-regulation of the immune response in normal and critically ill states
48. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6
49. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation
50. Transcription factors Stat3 and Stat5b are present in rat liver nuclei late in an acute phase response and bind interleukin-6 response elements
51. Synergistic action of interleukin-6 and glucocor ticoids is mediated by the interleukin-6 response element of the rat α2 macroglobulin gene
52. Structure of the rat insulin-like growth factor binding protein-4 gene